Ju Kim
@JuKimMD
Followers
221
Following
62
Statuses
43
Advanced heart failure and transplant cardiologist. Tweets are my own.
Texas Medical Center, Houston
Joined January 2020
RT @KharsaChloe: Meet the Houston Methodist Jeopardy team at #TCACC24!! Best of luck for this Jeopardy Sessionš„ @dr_chebrolu @NadeenFaza @ā¦
0
5
0
RT @HMHCardioFellow: š©ŗš The HMH Cardiology team is advancing heart care and making a real impact. #HMHCardiology #HeartHealth #Teamwork httā¦
0
13
0
Iām excited to invite you to the 9th Annual Houston Heart Failure Summit! Join us Saturday, 2/3/24 at @MethodistHosp or online. We are thrilled to have @DhariniRamu and @kamos16 as guest speakers reviewing the role of genetics in heart failure evaluation.
2
5
14
Thank you @mcolvin89 for joining us at @MethodistHosp and highlighting the importance of equity in access to advanced heart failure therapies! Look for the recording on the @DeBakeyCVedu YouTube channel to hear her insights into this critical issue.
0
1
5
Fantastic @HMethodistCV Grand Rounds by @RyanTedfordMD on RV assessment. Watch: Join @DeBakeyCVedu tomorrow for the George P. Noon Heart Failure Symposium to learn more from him and other leaders in the field of #LVAD! Register:
0
1
7
Fantastic @HMethodistCV Grand Rounds by @RyanTedfordMD on RV reserve. Watch here: Join @DeBakeyCVedu tomorrow at the George P. Noon Heart Failure Symposium to learn more from him and other leaders in the field of #LVAD. Register
0
5
23
@PanjrathG @richardkatz @JReinerMD @Tracy14Cynthia @GW_MFA @GWSMHS Congratulations and best wishes on your new role!
1
0
0
Honored to present the @MethodistHosp experience in forming a #cardiogenicshock team on the international stage. Thank you @GTorreAmione @vicentejmzmd @ErasmoPA and @TecSaludMX. Congrats on a great 1st Annual Symposium for Cardiogenic Shock and Heart Failure!
1
2
18
RT @valeriaduarteMD: Thrilled to welcome Dr. Quartiās exceptional experience in congenital surgery to support @HMethodistCV commitment to pā¦
0
3
0
RT @PSatishMD: 1/ Our RCT of med student guided tobacco cessation counseling of hospitalized patients in India #MSCHAT trial is published iā¦
0
26
0
Great discussion on the impact of tMCS has had on our field of HF by @AlpeshShahMD. Looking forward to PROTECT-IV at @HMethodistCV ! @SachinGoelMD @HuieLin @bobbi_hf @Abiomed
#HHFS2023 @AlpeshShahMD Let's talk next about HOW we do PCI! š„PROTECT-II: Impella-assisted better than IABP-assisted PCI. But why? šReduced complications šEnables optimal lesion selection šRenal protection
0
0
6
Join us THIS SATURDAY for an in depth review of the impact of co-morbid conditions on heart failure outcomes! Donāt miss the opportunity to interact with leaders in the field including @MarkDrazner and @robmentz! @HMinternalmed @HMHCardioFellow @HFSA
Need #CME and #CNE? Don't miss #HHFS2023 on Feb. 4! Hear the latest about #heartfailure, including updates on #cardiac and non-cardiac #comorbidities related to chronic heart failure. Register today #CardioEd #MedEd @JuKimMD @CindyMMartinMD
0
2
8
RT @DeBakeyCVedu: Interested in learning more about #heartfailure #comorbidities? Join us on Feb. 4 for #HHFS2023. Get in-depth info on topā¦
0
1
0
Incredibly blessed and proud to have @WilliamZoghbi as my chief and mentor. Truly an inspirational leader who sets the bar high & supports your efforts to surpass it. Congratulations on a well-deserved recognition! @HMHCardioFellow @MethodistHosp
Humbled & honored to be recognized by @ASE360 ā an amazing organization spearheading education and innovation at its core, along with its 17k+ members!
0
0
9
RT @DeBakeyCVedu: We are excited to announce our second keynote for #HHFS2023: @robmentz. He will kick off the second session by discussingā¦
0
4
0
RT @DeBakeyCVedu: We are excited to announce our first keynote speaker for #HHFS2023: @MarkDrazner! He will kick off the first session by dā¦
0
3
0
Join @DeBakeyCVedu on Saturday Feb 4 at the 8th Annual Houston Heart Failure Summit where @robmentz and @MarkDrazner will headline discussions on the latest in heart failure management such as this! @HFSA @HMHCardioFellow @HMethodistMD Register:
GLP-1R agonists & SGLT2 inhibitors are recommended first-line therapies for type 2 diabetes in patients with increased CV risk. Glucocentric Drugs in CV Disease Protection & Heart Failure @drtalhakhawaja @gcfmd @virani_md @JavedButler1
#DeBakeyCVJournal
0
2
5
RT @DeBakeyCVedu: Join us at the @TXMedCenter for #HHFS2023 on Feb. 4! Hear from experts, including @robmentz and @MarkDrazner, to get theā¦
0
3
0
RT @DeBakeyCVedu: Calling all #Cardiology 1st year fellows: SAVE THE DATE: #CVBootCamp2022 Aug 5-7! Don't miss the opportunity to get handā¦
0
5
0
RT @HJRyooAli: #TBT to #ISHLT2022 where our @HMethodistCV heart failure family š came together, shared, learned, and had so much fun! š§µScā¦
0
2
0